[{"Assets_0_Q3_USD":459094000.0,"EarningsPerShareBasic_1_Q3_USD":0.01,"EarningsPerShareBasic_3_Q3_USD":-0.14,"EarningsPerShareDiluted_1_Q3_USD":0.01,"EarningsPerShareDiluted_3_Q3_USD":-0.14,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":13598000.0,"NetIncomeLoss_1_Q3_USD":238000.0,"NetIncomeLoss_3_Q3_USD":-4426000.0,"StockholdersEquity_0_Q3_USD":383832000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":35664272.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":32766135.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":33446841.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":32766135.0,"Ticker":"PEN","CIK":"1321732","name":"PENUMBRA INC","OfficialName":"Penumbra Inc. Common Stock","form":"10-Q","period":"20170930","fy":"2017.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"7821675869.0","Country":"nan","Sector":"Health Care","Industry":"Medical\/Dental Instruments","Market":"NYSE","SP500":"nan","filed":"20171107"}]